Rate My Professor Karen Guillemin

Guillemin pioneered the use of zebrafish, including gnotobiotic and germ-free models, to dissect host-microbe interactions. Her research elucidates how animals coexist with microbial communities, the influence of the gut microbiome on intestinal development, metabolism, immunity, and behavior, bacterial strategies for host colonization including chemotaxis and adhesion, and the assembly of host-associated microbial communities. Key discoveries include a novel bacterial protein BefA that induces proliferation of insulin-producing pancreatic beta cells, patented for potential Type 1 diabetes therapeutics; bacterial proteins modulating inflammation relevant to Crohn's disease; and a Helicobacter pylori protein that directs bacteria to inflamed gastric tissue linked to ulcers and cancer. She has published over 85 scientific papers, including a landmark 2006 study demonstrating stunted development in germ-free zebrafish intestines and contributions such as 'Contribution of neutral processes to the assembly of gut microbial communities in the zebrafish intestine' (2015). Guillemin's work has profoundly impacted the field by establishing zebrafish as a premier model for microbiome research. Honors include election to the American Academy of Arts and Sciences (2020), AAAS Fellow (2020), American Academy of Microbiology (2016), Burroughs Wellcome Fund Career Award in Biomedical Sciences (2001), and Medical Research Foundation of Oregon Discovery Award.